查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032337

手術部位感染控制市場報告：按產品、感染類型、手術方式、最終用戶和地區分類（2026-2034 年）

Surgical Site Infection Control Market Report by Product, Infection Type, Surgery Type, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球手術部位感染（SSI）預防市場規模達49億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到68億美元，2026年至2034年的複合年成長率（CAGR）為3.45%。市場成長的主要促進因素包括手術數量的增加、人們對醫療相關感染的認知不斷提高、對病人安全的日益重視以及醫療成本的飆升。

手術部位感染控制市場趨勢

老年人口增加

世界許多地區正在經歷人口結構變化，65歲及以上人口的比例不斷增加。例如，世界衛生組織（世衛組織）預測，到2030年，全球每六個人中就有一人年滿60歲或以上。屆時，60歲及以上人口預計將從2020年的10億增加到14億。到2050年，全球60歲以上人口預計將加倍，達到21億人。 80歲及以上人口數預計將在2020年至2050年間成長兩倍，達到4.26億。由於免疫系統老齡化成長而變化、組織癒合能力下降以及合併糖尿病、高血壓和心血管疾病等疾病，老年人更容易發生手術部位感染（SSI）。隨著老年人口的成長，老年人接受手術的數量也在增加，這導致對感染控制措施的需求日益成長，以降低手術部位感染（SSI）的風險。例如，根據美國國家醫學圖書館2021年3月發表的一篇論文，每年約有400萬例手術是在65歲及以上的老年人中進行的。與之相關的是，美國國家醫學圖書館2023年3月發表的另一篇論文指出，在全膝關節置換術中，76-80歲患者的手術部位感染發生率高於61-65歲患者。這些因素進一步推動了與手術部位感染相關的市場收入成長。

手術數量增加和醫療基礎設施發展

全球手術量正顯著成長。例如，根據美國國家醫學圖書館發表的報導，截至2020年9月，全球11%的疾病負擔需要手術介入、麻醉管理或兩者兼有。最常見的手術是白內障手術（22.8%）、剖腹產（3.8%）、骨折手術（3.27%）和疝氣手術（2.86%）。必要的手術佔所有手術的44.2%。此外，醫療基礎設施建設，尤其是在新興市場，正在推動手術部位感染控制市場的成長。根據印度投資網發表的報導，預計2025年，公共醫療支出將達到GDP的2.5%。同時，醫療機構和醫護人員正增加對預防策略和技術的投資，以最大限度地減少手術部位感染的發生率。這包括採用嚴格的操作規程、先進的滅菌技術、在手術器械上使用抗菌塗層，以及在傷口敷料和縫線中使用高科技材料。例如，2023年12月，弗林德斯大學和中國的研究人員共同開發了一種新型的基於銀鎵（Ag-Ga）的整形外科植入敷料，該敷料具有極高的抗感染能力。這種新型材料可以透過噴塗技術輕鬆、精確地應用於多種醫療設備，在提供感染防護的同時，也具有抗發炎作用。此外，2023年10月，Sylke公司發布了“SYLKE”，這是一種由純淨、低致敏性絲素蛋白製成的敷料。 SYLKE能夠促進手術傷口癒合，減少可能導致疤痕不良的併發症和感染。 SYLKE旨在透過消除醫用黏合劑造成的皮膚損傷（這些傷害會導致感染和疤痕不良），從而革新手術傷口護理方式。

研究和臨床試驗的進展

研究和臨床試驗的進展在推動手術部位感染 (SSI) 管理市場成長方面發揮著至關重要的作用，它們加速了創新產品的開發，強化了治療策略，並改善了患者預後。例如，2024 年 2 月，專注於改善手術預後的生物製藥公司 PolyPid Ltd. 宣布，其 SHIELD II III 期臨床試驗在完成第 100 例患者入組後取得了顯著進展。該研究檢驗了候選產品 D-PLEX100 的療效，該產品旨在預防腹部和結直腸手術後的傷口感染。 SHIELD II 試驗的主要結果預計將於 2024 年下半年公佈，目前約有 40 個研究中心參與試驗。此外，研究和臨床試驗也有助於制定手術環境中感染預防和控制的最佳實踐和指南。實證醫學建議涵蓋術前準備、手術技巧、抗生素預防和術後護理等方面，有助於規範操作流程，提高感染控制措施的依從性，最終降低手術部位感染 (SSI) 的發生率，改善患者預後。例如，2023 年 8 月，埃默里大學進行的一項涉及 2 萬多名患者的研究發現，採用自動化方法提供回饋和評估績效，可使抗生素預防依從性提高 12%，並將手術部位感染的總體發生率降低 33%。在 2023 年外科感染疾病學會年會上公佈的數據表明，一種獨特的自動化抗生素預防方法可顯著降低手術部位感染的發生率。這些因素進一步推動了手術部位感染管理市場的積極發展。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球手術部位感染控制市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 抗菌防護產品
  • 創傷護理敷料
  • 外科用覆蓋巾
  • 手術剪鉗
  • 防腐劑和消毒劑
  • 傷口清潔產品
  • 其他

第7章 市場區隔：依感染類型分類

  • 表切口SSI
  • 深切口SSI
  • 器官或部位特異性手術部位感染

第8章 市場區隔：依手術類型分類

  • 剖腹產
  • 胃繞道手術
  • 白內障手術
  • 牙齒修復
  • 其他

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • 3M Company
    • Ansell Limited
    • Becton Dickinson and Company
    • bioMerieux SA.（Institut Merieux）
    • Covalon Technologies Ltd.
    • GAMA Healthcare Ltd.
    • Getinge AB（Carl Bennet AB）
    • Johnson & Johnson
    • Kimberly-Clark Corporation
    • Molnlycke Health Care AB
    • Prescient Surgical
    • Steris Corporation
Product Code: SR112026A5669

The global surgical site infection control market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.8 Billion by 2034, exhibiting a growth rate (CAGR) of 3.45% during 2026-2034. The increasing surgical procedures, growing awareness about healthcare-associated infections, enhanced focus on patient safety, and surging healthcare expenditure are some of the major factors propelling the market growth.

Surgical Site Infection Control Market Analysis:

Major Market Drivers: The rising cases of hospital-acquired infections and the increasing prevalence of chronic conditions, such as cancer, gastrointestinal disorders, cardiovascular diseases (CVDs), etc., due to the aging population, sedentary lifestyles, and unhealthy eating habits are propelling the adoption of surgical site infection control. Moreover, several favorable initiatives undertaken by the governing and non-governing agencies of various countries, such as the introduction of stringent guidelines and training programs focused on infection control practices, are propelling the surgical site infection control market.

Key Market Trends: The increasing prevalence of surgical site infections, ongoing technological advancements in infection control products, rising adoption of minimally invasive surgeries, and introduction of stringent regulatory standards are expected to propel the surgical site infection control market demand. Moreover, with the rise in healthcare expenditure globally, there is a growing focus on improving patient outcomes and reducing healthcare-associated infections, including SSIs. This trend is expected to drive the demand for advanced infection control solutions in surgical settings.

Competitive Landscape: Some of the leading surgical site infection control market companies are 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Merieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Molnlycke Health Care AB, Prescient Surgical, and Steris Corporation, among many others.

Geographical Trends: According to the report, North America currently dominates the overall market. The region represents one of the largest markets for surgical site infection control products and services globally. The market size is influenced by factors such as the increase in the number of surgical procedures, advanced healthcare infrastructures, wide presence of regulatory landscape, ongoing technological innovations, etc. The market has been experiencing steady growth due to the increasing awareness about healthcare-associated infections and the importance of infection prevention measures.

Challenges and Opportunities: Antibiotic resistance, compliance issues, cost consideration, and variations in surgical practices and protocols across different healthcare facilities are some of the challenges that the market is facing. However, advances in medical technology, such as the development of antimicrobial coatings, novel surgical materials, and robotic-assisted surgery, offer the surgical site infection control market recent opportunities to enhance infection control in surgical settings.

Surgical Site Infection Control Market Trends:

Rising Geriatric Population

Many regions worldwide are experiencing a demographic shift characterized by a growing proportion of older adults aged 65 and above. For instance, according to the World Health Organization, by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of persons aged 60 and up will double (2.1 billion). The number of people aged 80 and older is anticipated to treble between 2020 and 2050, reaching 426 million. Older adults are more vulnerable to SSIs due to age-related changes in the immune system, reduced tissue healing capacity, and the presence of comorbidities such as diabetes, hypertension, and cardiovascular disease. As the geriatric population grows, there is a corresponding increase in the number of surgical procedures performed on older adults, leading to a higher demand for infection control measures to mitigate the risk of SSIs. For instance, according to an article published by the National Library of Medicine in March 2021, nearly 4 million surgical procedures were performed each year in older adults aged 65 years and above. In line with this, according to another article published by the National Library of Medicine in March 2023, in total knee replacement surgery, the SSI rates were higher in older adults aged 76-80 years when compared with the age group of 61-65 years. These factors are further bolstering the surgical site infection market revenue.

Increasing Surgical Procedure and Healthcare Infrastructure Development

There has been a significant increase in surgical procedures across the world. For instance, according to an article published by the National Library of Medicine, in September 2020, 11% of the world's illness burden necessitates surgical intervention, anesthetic management, or both. The most common procedures were for cataracts (22.8%), Caesareans (3.8%), fracture surgeries (3.27%), and hernias (2.86%). The necessary operations made up 44.2% of all surgeries. Moreover, healthcare infrastructure development initiatives, particularly in emerging markets, contribute to the growth of the surgical site infection control market. According to an article published by the India Investment Grid, public health expenditure is expected to rise to 2.5% of GDP by 2025. Apart from this, healthcare facilities and providers are increasingly investing in preventive strategies and technologies to minimize the incidence of SSIs. This includes the adoption of stringent protocols, advanced sterilization techniques, antimicrobial coatings for surgical instruments, and the utilization of high-tech materials in wound dressings and sutures. For instance, in December 2023, Flinders University and Chinese researchers collaborated to develop a new Ag-Ga orthopedic implant covering that is highly resistant to infection. The novel material could be readily and controllably put by spray-casting on numerous medical devices to protect them from infection while simultaneously providing an anti-inflammatory impact. Moreover, in October 2023, Sylke Inc. introduced SYLKE, the dressing manufactured from pure hypoallergenic silk fibroin. SYLKE promotes healing in surgical wounds and reduces complications and infections that might cause poor scarring. SYLKE seeks to transform surgical wound care by removing medical adhesive-related skin damage that causes infections and poor scarring outcomes.

Advances in Research Studies and Clinical Trials

Advances in research studies and clinical trials play a crucial role in driving growth in the surgical site infection control market by facilitating the development of innovative products, enhancing treatment strategies, and improving patient outcomes. For instance, in February 2024, PolyPid Ltd., a biopharmaceutical company dedicated to improving surgical outcomes, announced considerable progress in its SHIELD II Phase 3 clinical study, after enrolling its 100th patient. This research looked at the efficacy of D-PLEX100, a product candidate intended to prevent surgical site infections (SSIs) in abdominal colorectal procedures. Top-line results from the SHIELD II trial were expected in the second half of 2024, with about 40 locations actively participating in the study. Moreover, research studies and clinical trials contribute to the identification of best practices and guidelines for infection prevention and control in surgical settings. Evidence-based recommendations regarding preoperative preparation, surgical techniques, antimicrobial prophylaxis, and postoperative care help standardize protocols and improve adherence to infection control measures, ultimately reducing the incidence of SSIs and improving patient outcomes. For instance, in August 2023, Emory University performed research which included over 20,000 patients and used automated methods to provide feedback and evaluate performance, found a 12% increase in antibiotic prophylactic compliance and a 33% decrease in overall SSIs. Data presented at the Surgical Infection Society's 2023 annual meeting showed that a unique automated antibiotic prophylaxis approach significantly reduces surgical site infections. These factors are further positively influencing the surgical site infection control market forecast.

Surgical Site Infection Control Market Segmentation:

This report provides an analysis of the key trends in each segment of the global surgical site infection control market report, along with forecasts at the global, regional, and country levels from 2026-2034. The report categorizes the market based on product, infection type, surgery type, and end user.

Breakup by Product:

  • Antibiotic Prophylaxis Products
  • Wound Care Dressings
  • Surgical Drapes
  • Surgical Clippers
  • Antiseptics and Disinfectants
  • Wound Irrigation Products
  • Others

Antibiotic prophylaxis products currently exhibit a clear dominance in the market

According to the surgical site infection control market outlook, antibiotic prophylaxis plays a crucial role in preventing surgical site infections (SSIs), which are a significant concern in healthcare settings. Antibiotics are usually administered shortly before surgical incision to achieve adequate tissue concentrations at the time of potential bacterial contamination. The timing of administration is critical and should ideally occur within 60 minutes before the surgical incision, although exceptions may exist for certain antibiotics and procedures. Moreover, prophylactic antibiotic regimens are often tailored to the specific requirements of different surgical procedures. For example, orthopedic surgeries may require coverage against Staphylococcus aureus and streptococci, while colorectal surgeries may necessitate additional coverage against gram-negative and anaerobic bacteria. For instance, in January 2024, the American Association for the Surgery of Trauma (AAST), the World Surgical Infection Society Europe (SIS-E), the Global Alliance for Infection in Surgery (GAIS), and the World Society of Emergency Surgery (WSES) collaborated to develop important guidelines for antibiotic prophylaxis (AP) in cases of traumatic lesions involving the head, brain, torso, maxillofacial region, extremities, skin, and soft tissues.

Breakup by Infection Type:

  • Superficial Incisional SSI
  • Deep Incisional SSI
  • Organ or Space SSI

Currently, superficial incisional SSI accounts for the majority of the global market share

According to the surgical site infection market overview, superficial incisional surgical site infections (SSIs) represent a significant portion of all SSIs. These infections occur within 30 days after the operation and involve only the skin and subcutaneous tissue of the incision. They are often characterized by symptoms such as redness, warmth, swelling, and localized pain at the surgical site. They are among the most common types of SSIs encountered in surgical practice. Their relatively high incidence underscores their importance in infection control efforts. For instance, according to an article published by the National Library of Medicine in 2023, 59% of the total SSI patients had superficial SSI.

Breakup by Surgery Type:

  • Cesarean Section
  • Gastric Bypass
  • Cataract Surgery
  • Dental Restoration
  • Others

Cesarean section currently holds the largest market share

Cesarean sections are one of the most common surgical procedures globally. In many countries, the rates of C-section deliveries have been increasing steadily over the years. With such a high volume of procedures, the prevention of SSIs in C-sections becomes a significant focus of infection control efforts. Moreover, the surgical site in a Cesarean section is particularly vulnerable to infection due to its proximity to the genital and gastrointestinal tracts, which harbor numerous bacteria. Additionally, the procedure involves breaching the protective barriers of the skin and uterine wall, increasing the risk of contamination. Apart from this, SSIs following Cesarean sections can have serious consequences for both the mother and the newborn. In addition to causing discomfort and prolonging hospital stays for the mother, SSIs can lead to complications such as endometritis, wound dehiscence, sepsis, and increased healthcare costs. There's also a risk of vertical transmission of pathogens to the newborn, which can result in neonatal infections. For instance, according to World Health Organization (WHO) data, the use of cesarean sections is increasing, accounting for more than one in every five (21%) childbirths in 2021. This figure is expected to rise further over the next decade, with almost one-third (29%) of all births by cesarean section by 2030.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Currently, hospitals exhibit a clear dominance in the market

The demand for surgical site infection (SSI) control in hospitals arises from various factors related to patient safety, healthcare quality, regulatory requirements, and financial considerations. Preventing SSIs is essential for ensuring patient safety and minimizing the risk of postoperative complications. SSIs can lead to significant morbidity, prolonged hospital stays, increased healthcare costs, and in severe cases, mortality. Hospitals have a moral and ethical obligation to provide safe and high-quality care to their patients, which includes implementing measures to control SSIs. Moreover, hospitals are increasingly focused on delivering high-quality care and maintaining a positive reputation within their communities. Preventing SSIs is a fundamental aspect of healthcare quality improvement efforts. Hospitals that effectively control SSIs are perceived as safer and more reliable by patients, healthcare professionals, insurers, and regulatory agencies.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America currently dominates the global market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.

According to the surgical site infection control market statistics, North America represents one of the largest markets for healthcare products and services globally. Within this context, the SSI control market encompasses a wide range of products, including antimicrobial agents, surgical drapes, gloves, sterilization equipment, wound care products, and surveillance systems. Despite advances in surgical techniques and infection control practices, SSIs remain a significant concern in North American healthcare facilities. The prevalence of SSIs varies across different surgical specialties and settings but represents a substantial clinical and economic burden on healthcare systems. For instance, in February 2021, Penn Medicine opened its new Interventional Support Center (ISC), making it one of the most prominent instrument processing and surgical supply preparation facilities in Southwest Philadelphia, United States. The ISC is one of Pennsylvania's first facilities of its sort, with staff sterilizing and packaging thousands of instruments daily in preparation for surgeries and procedures, ranging from basic scissors and clamps to complex robotic instruments. For instance, according to an article published by the National Library of Medicine, in February 2024, surgical site infections accounted for approximately two million nosocomial infections in the U.S., which considerably raises postoperative morbidity and mortality rates. In line with this, according to the international trial co-led by McMaster University and the University of Maryland School of Medicine in February 2024, thousands of patients yearly undergoing surgery for a closed fracture may avoid surgical site infections by using iodine povacrylex in alcohol to disinfect their skin.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players that are mentioned below:

  • 3M Company
  • Ansell Limited
  • Becton Dickinson and Company
  • bioMerieux SA. (Institut Merieux)
  • Covalon Technologies Ltd.
  • GAMA Healthcare Ltd.
  • Getinge AB (Carl Bennet AB)
  • Johnson & Johnson
  • Kimberly-Clark Corporation
  • Molnlycke Health Care AB
  • Prescient Surgical
  • Steris Corporation

Key Questions Answered in This Report

1. How big is the surgical site infection control market?

2. What is the expected growth rate of the global surgical site infection control market during 2026-2034?

3. What are the key factors driving the global surgical site infection control market?

4. What has been the impact of COVID-19 on the global surgical site infection control market?

5. What is the breakup of the global surgical site infection control market based on the product?

6. What is the breakup of the global surgical site infection control market based on the infection type?

7. What is the breakup of the global surgical site infection control market based on the surgery type?

8. What is the breakup of the global surgical site infection control market based on the end user?

9. What are the key regions in the global surgical site infection control market?

10. Who are the key players/companies in the global surgical site infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Surgical Site Infection Control Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibiotic Prophylaxis Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Wound Care Dressings
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Surgical Drapes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgical Clippers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antiseptics and Disinfectants
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Wound Irrigation Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Infection Type

  • 7.1 Superficial Incisional SSI
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Deep Incisional SSI
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Organ or Space SSI
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Surgery Type

  • 8.1 Cesarean Section
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastric Bypass
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cataract Surgery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Dental Restoration
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 3M Company
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Ansell Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 bioMerieux SA. (Institut Merieux)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Covalon Technologies Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 GAMA Healthcare Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Getinge AB (Carl Bennet AB)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Kimberly-Clark Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Molnlycke Health Care AB
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 Prescient Surgical
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Steris Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Surgical Site Infection Control Market: Major Drivers and Challenges
  • Figure 2: Global: Surgical Site Infection Control Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Surgical Site Infection Control Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Surgical Site Infection Control Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Surgical Site Infection Control Market: Breakup by Infection Type (in %), 2025
  • Figure 6: Global: Surgical Site Infection Control Market: Breakup by Surgery Type (in %), 2025
  • Figure 7: Global: Surgical Site Infection Control Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Surgical Site Infection Control Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Surgical Site Infection Control (Antibiotic Prophylaxis Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Surgical Site Infection Control (Antibiotic Prophylaxis Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Surgical Site Infection Control (Wound Care Dressings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Surgical Site Infection Control (Wound Care Dressings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Surgical Site Infection Control (Surgical Drapes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Surgical Site Infection Control (Surgical Drapes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Surgical Site Infection Control (Surgical Clippers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Surgical Site Infection Control (Surgical Clippers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Surgical Site Infection Control (Antiseptics and Disinfectants) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Surgical Site Infection Control (Antiseptics and Disinfectants) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Surgical Site Infection Control (Wound Irrigation Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Surgical Site Infection Control (Wound Irrigation Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Surgical Site Infection Control (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Surgical Site Infection Control (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Surgical Site Infection Control (Superficial Incisional SSI) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Surgical Site Infection Control (Superficial Incisional SSI) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Surgical Site Infection Control (Deep Incisional SSI) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Surgical Site Infection Control (Deep Incisional SSI) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Surgical Site Infection Control (Organ or Space SSI) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Surgical Site Infection Control (Organ or Space SSI) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Surgical Site Infection Control (Cesarean Section) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Surgical Site Infection Control (Cesarean Section) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Surgical Site Infection Control (Gastric Bypass) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Surgical Site Infection Control (Gastric Bypass) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Surgical Site Infection Control (Cataract Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Surgical Site Infection Control (Cataract Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Surgical Site Infection Control (Dental Restoration) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Surgical Site Infection Control (Dental Restoration) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Surgical Site Infection Control (Other Surgery Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Surgical Site Infection Control (Other Surgery Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Surgical Site Infection Control (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Surgical Site Infection Control (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Surgical Site Infection Control (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Surgical Site Infection Control (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Surgical Site Infection Control (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Surgical Site Infection Control (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: North America: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: North America: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: United States: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: United States: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Canada: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Canada: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Asia-Pacific: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Asia-Pacific: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: China: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: China: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Japan: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Japan: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: India: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: India: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: South Korea: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: South Korea: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Australia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Australia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Indonesia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Indonesia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Europe: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Europe: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Germany: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Germany: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: France: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: France: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: United Kingdom: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: United Kingdom: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Italy: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Italy: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Spain: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Spain: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Russia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Russia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Latin America: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Latin America: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Brazil: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Brazil: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Mexico: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Mexico: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Middle East and Africa: Surgical Site Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Middle East and Africa: Surgical Site Infection Control Market: Breakup by Country (in %), 2025
  • Figure 93: Middle East and Africa: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Global: Surgical Site Infection Control Industry: SWOT Analysis
  • Figure 95: Global: Surgical Site Infection Control Industry: Value Chain Analysis
  • Figure 96: Global: Surgical Site Infection Control Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Surgical Site Infection Control Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Surgical Site Infection Control Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Surgical Site Infection Control Market Forecast: Breakup by Infection Type (in Million USD), 2026-2034
  • Table 4: Global: Surgical Site Infection Control Market Forecast: Breakup by Surgery Type (in Million USD), 2026-2034
  • Table 5: Global: Surgical Site Infection Control Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Surgical Site Infection Control Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Surgical Site Infection Control Market: Competitive Structure
  • Table 8: Global: Surgical Site Infection Control Market: Key Players